Patients' symptom concerns before anticancer treatment predict symptom burdens

Patients' symptom concerns before anticancer treatment predict symptom burdens
Patients' symptom concerns before anticancer treatment predict symptom burdens

CHICAGO, IL— Patients who express pretreatment concern about treatment symptoms such as nausea and memory problems tend to suffer higher symptom burdens during and after anticancer treatment, suggests research presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting.

Patients with high levels of concern about symptoms before anticancer treatment, and who wanted more information on symptom management before treatment, suffered more from fatigue, pain, nausea, memory and concentration issues, and depression during and after treatment (total symptom score, P < .001), researchers reported.

“Clinicians should consider using these questions as indicators to which patients may require additional symptom management care,” said lead author Luke Joseph Peppone, PhD, of the University of Rochester Medical Center in Rochester, New York, and coauthors. “Asking Patients about their expected symptom burden and information needs before treatment is a quick and easy-to-administer predictor of symptom burden throughout the cancer treatment process.”

A total of 972 participants were scheduled to receive radiotherapy and/or chemotherapy for cancer; they prospectively completed symptom concerns surveys before, during, and 6 months after treatment (n=652 completed surveys at 6 months). During and after treatment, patients reported the severity of 12 symptoms on an 11-point subjective scale: fatigue, hair loss, memory, nausea, depression, sleep, pain, concentration, hot flashes, weight loss, skin problems, and dyspnea.

Abstract #9650

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs